Skip to Content Facebook Feature Image

China's top political advisor meets Harvard professor

China

China

China

China's top political advisor meets Harvard professor

2026-03-20 20:34 Last Updated At:03-21 14:30

China's top political advisor Wang Huning met with Harvard University Professor Graham Allison in Beijing on Friday.

Wang, chairman of the National Committee of the Chinese People's Political Consultative Conference (CPPCC), said President Xi Jinping and President Donald Trump maintain good interactions, providing important strategic guidance for China-U.S. relations to improve and move forward.

Noting this year marks the start of China's 15th Five-Year Plan (2026-2030), Wang said China will respond to the ever-changing international situation with certainty via its own development.

Wang stressed the Taiwan question is at the very core of China's core interests. China and the United States should strengthen dialogue and communication, properly manage differences, expand pragmatic cooperation, and find the right way to get along, injecting certainty and positive energy into the world, he said.

For his part, Allison said when international peace and order are gravely eroding, finding the right way for the two major countries to get along with each other is crucial for the world.

He hailed the three principles of mutual respect, peaceful coexistence and win-win cooperation proposed by President Xi for developing China-U.S. relations as highly enlightening.

Allison hopes that the United States and China will properly handle the Taiwan question and other issues to promote the steady development of bilateral relations, which also meets the expectations of the world.

China's top political advisor meets Harvard professor

China's top political advisor meets Harvard professor

China's top political advisor meets Harvard professor

China's top political advisor meets Harvard professor

China's Minister of Commerce Wang Wentao met with global pharmaceutical leaders in Beijing for a high-level dialogue.

The meeting brought together policymakers and senior executives from multinational drugmakers including Novartis, AstraZeneca, Roche, Boehringer Ingelheim and Organon.

"The pharmaceutical industry is vital to human health, we welcome your views and suggestions on development in China,” Wang said while addressing participants at the high-level dialogue.

Drawing growing global attention, China is now one of the world’s fastest-evolving markets and is signaling openness by inviting deeper engagement from multinational companies already investing in the country, according to U.S. pharmaceutical officials.

"For the innovative pharmaceutical sector, China has become one of the world's largest and fastest evolving markets, playing an increasingly global role," said Stephen J. Ubl, president and chief executive officer of the Pharmaceutical Research and Manufacturers of America (PhRMA).

From cutting-edge biotech to large-scale manufacturing, global firms say China’s appeal lies in its unique combination of scale and capabilities.

"Key factors in this evolution include China's large patient population, scientific talent, clinical research capacity, and investments in science and healthcare," said Ubl.

China’s commerce minister meets global pharma leaders

China’s commerce minister meets global pharma leaders

Recommended Articles